Mok TS - Search Results

1

Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers.

Sy SM, Fan B, Lee TW, Mok TS, Pang E, Yim A, Wong N. Sy SM, et al. Among authors: mok ts. Cancer Genet Cytogenet. 2004 Aug;153(1):57-9. doi: 10.1016/j.cancergencyto.2003.11.013. Cancer Genet Cytogenet. 2004. PMID: 15325095

2

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.

Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P. Mok TS, et al. Cancer. 2002 Oct 1;95(7):1511-9. doi: 10.1002/cncr.10836. Cancer. 2002. PMID: 12237920 Free article. Clinical Trial.

3

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.

Lee TW, Chen GG, Xu H, Yip JH, Chak EC, Mok TS, Yim AP. Lee TW, et al. Among authors: mok ts. Eur J Cancer. 2003 Jun;39(9):1296-301. doi: 10.1016/s0959-8049(02)00733-5. Eur J Cancer. 2003. PMID: 12763220

4

Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.

Sy SM, Wong N, Mok TS, Tsao MS, Lee TW, Tse G, Blackhall FH, Johnson PJ, Yim AP. Sy SM, et al. Among authors: mok ts. Lung Cancer. 2003 Jul;41(1):91-9. doi: 10.1016/s0169-5002(03)00138-7. Lung Cancer. 2003. PMID: 12826317

5

Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.

Sy SM, Wong N, Lee TW, Tse G, Mok TS, Fan B, Pang E, Johnson PJ, Yim A. Sy SM, et al. Among authors: mok ts. Eur J Cancer. 2004 May;40(7):1082-94. doi: 10.1016/j.ejca.2004.01.012. Eur J Cancer. 2004. PMID: 15093586

6

Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma.

Chen GG, Lee TW, Yip JH, Xu H, Lee IK, Mok TS, Warner TD, Yim AP. Chen GG, et al. Among authors: mok ts. Cancer Lett. 2006 Mar 28;234(2):193-8. doi: 10.1016/j.canlet.2005.03.032. Cancer Lett. 2006. PMID: 15876485

7

Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.

Mok TS, Lam KC, Lee C, Zhang L, Wong H, Chan AT, Yeo W, Yim AP, Chak K, Zee B. Mok TS, et al. Oncology. 2005;68(4-6):485-92. doi: 10.1159/000086992. Epub 2005 Jul 13. Oncology. 2005. PMID: 16020979 Clinical Trial.

8

Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.

Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG. Li M, et al. Among authors: mok ts. J Cell Biochem. 2005 Nov 1;96(4):760-74. doi: 10.1002/jcb.20474. J Cell Biochem. 2005. PMID: 16149072

9

Clear cell carcinoma of the lung revisited.

Garzon JC, Lai FM, Mok TS, Manlulu AV, Ng CS, Lee TW, Yim AP. Garzon JC, et al. Among authors: mok ts. J Thorac Cardiovasc Surg. 2005 Oct;130(4):1198-9. doi: 10.1016/j.jtcvs.2005.04.030. J Thorac Cardiovasc Surg. 2005. PMID: 16214540 Free article. No abstract available.

10

Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.

Li M, Lee TW, Yim AP, Mok TS, Chen GG. Li M, et al. Among authors: mok ts. J Cell Physiol. 2006 Nov;209(2):428-38. doi: 10.1002/jcp.20738. J Cell Physiol. 2006. PMID: 16883598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters